| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Canada | 3 | |
| #4 | United States | 3 | |
| #5 | France | 2 | |
| #6 | Australia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kadouche Jean | 17 |
| #2 | Levy Rafael | 7 |
| #3 | Lechuga Marc | 4 |
| #4 | Roseto Alberto | 4 |
| #5 | Chose Olivier | 4 |
| #6 | Boumsell Laurence | 2 |
| #7 | Didierlaurent Denis | 2 |
| #8 | Sabbah-Petrover Emmanuelle | 2 |
| #9 | Bensussan Armand | 1 |
| #10 | Lecomte Nicolas | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP2210903A1 | Anti-CD160 monoclonal antibodies and uses thereof | |
| EP2009028A1 | Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors | |
| US2006286030A1 | Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells | |
| FR2856075A1 | ESSENTIALLY AUTOMATED LARGE-SCALE SCREENING METHOD OF CELLS SECURING MONOCLONAL ANTIBODIES | |
| FR2804027A1 | Use of monoclonal anti-ferritin antibodies in the treatment of certain cancers |